Spectrum Pharmaceuticals, Inc.
News
Spectrum Pharmaceuticals (NASDAQ:SPPI) Research Coverage Started at StockNews.com
Zolmax Research analysts at StockNews.com assumed coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI Get Free Report) in a note issued to investors on Tuesday. The firm set a hold rating on the biotechnology companys stock. Other analysts also recently issued reports about the company. HC ...\n more…
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Given Average Recommendation of "Hold" by Brokerages
Zolmax Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI Get Free Report) have earned a consensus recommendation of Hold from the five ratings firms that are currently covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation. The average 12-month ...\n more…
Spectrum Pharmaceuticals (NASDAQ:SPPI) Coverage Initiated by Analysts at StockNews.com
Ticker Report StockNews.com assumed coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI Free Report) in a research report released on Tuesday . The brokerage issued a hold rating on the biotechnology companys stock. Several other research firms have also commented on SPPI. HC Wainwright ...\n more…
Brokerages Set Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Price Target at $2.44
Ticker Report Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI Get Free Report) has been given a consensus recommendation of Hold by the five brokerages that are covering the firm, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation. The average 1-year price...\n more…
Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals
Globe Newswire Stockholders From Both Assertio and Spectrum Have Overwhelmingly Voted in Support of the Transaction Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill. and BOSTON, July 27, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT...\n more…
Spectrum Pharmaceuticals (NASDAQ:SPPI) Earns Hold Rating from Analysts at StockNews.com
Zolmax Investment analysts at StockNews.com assumed coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI Get Free Report) in a research note issued to investors on Monday. The brokerage set a hold rating on the biotechnology companys stock. A number of other equities analysts have also commented on ...\n more…